This is the deck I used for our Series A at Virti. We ended up raising $10M with IQ Capital, Cedars-Sinai Medical Center and a few others.
You can find the whole process and breakdown at https://blog.alexanderfyoung.com
2. The Problem
Ability
To
Scale
Effectiveness Of Learning
Traditional Learning
Videos and
Webinars
1-1 Expert Mentorship
Lectures &
Workshops
On-The-Job Training
Manuals &
e-Learning
Our mission is to improve human
performance by making
experiential education affordable
and accessible to everyone
Simulation &
Role Play
Remote
Events
Traditional training is not scalable and lacks objective data leaving your workforce underprepared
3. The corporate training market is fragmented and growing fast
$170bn (CAGR 4.3%) Global Workplace Training
$87.6bn (CAGR 17%) Healthcare Training
$41.7bn (CAGR 17.3%) Patient Education
$8bn (CAGR 10.3%) Medical Device Education
The Market:
Corporate Training
4. The Market:
Healthcare
Training
In our initial target market of healthcare education access to training is unequal and based on resources and geography
For Patients
Safety
250k
Deaths
$2.7bn
Training
For Organisations
Cost
Causes Of Death
U.S. Per Year
2597k
Cancer
585k
Medical
Error
250k
Heart
Disease
611k
COPD
149k
Suicide
41K
Firearms
34k
Motor
Vehicles
34k
For The Workforce
Stress
$20bn
Errors
5. The Product
We built the first end-to-end enterprise training solution allowing organisations to Create, Scale and Analyse experiential training
Create Distribute
Content Suite Mobile & Desktop,
VR and AR
Analyse
AI content analysis, user
performance analysis
AI Virtual Humans (mobile, desktop, AR and VR)
Creation Suite (2D, VR and AR)
Analytics
Engine
Cloud Platform
6. Decision-Making Speed
Engagement
Confidence Anxiety & Stress
Winner SimGHOSTS
Innovation Prize
Winner ASME TEL and
TIE Awards
Winner BOA Simulation
Prize
Skill Fade
Value To
Customers Independent research has validated impact and ROI
0
10
20
30
40
50
60
70
80
90
100
0 2 4 6 8 10 12
Virti In-Person
Month
Knowledge
retention
(%)
7. Seed to
Series A
$1.2M (of $2m Seed)
Spent in 18 months to reach…
$xxM
In sales revenue with…
$xxk
Monthly burn
x months
Runway*
978%
YoY Growth
We’ve been capital efficient
*Assuming current burn and 0% growth
8. Annualised
Revenue
Our revenue grew 978% August 2019 - August 2020
0
200000
400000
600000
800000
1000000
1200000
1400000
1600000
1800000
2000000
Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20
Year to date operating costs YTD Revenue YTD Cost of sales
USD
($)
9. Sales Unit
Economics We built a predictable sales organisation going into Series A
$xx
ACV
$xxM ARR
/SDR/Year
4-Months
Average Sales Cycle
2-Months
Average Sales Ramp
x1 SDR produces 1-2 contracts per month
0 Months 12 Months
Industry Average 3-months Healthcare Average 12-months
Q1 20 Q2 20 Q3 20
Spend as %
Revenue
12 15 18
LTV/CAC 2.3 2.7 3.1
Magic Number* 3.2 2.7 2.1
*Includes fixed headcount costs
=
10. Net Revenue
Retention We upsell and cross-sell our customers quickly in the first 90
days
0
Logo
Churn
110%
Net Revenue
Retention
xx
Enterprise Customers
Day 0
First Close
Day 30
80 Extra
Licenses
Day 60
Cross
Dept Sell
Day 70
Positive Case Study
Day 90
75% net rev increase
Enhanced functionality and increased value for the organisation
Expansion within organisations
11. Exec Team
Dr Alex Young CEO
Orthopaedic Surgeon with postgraduate
degrees in surgery and education.
Nils Hellberg CTO
Director of Bristol Games Hub, Worked
across multiple video streaming companies
We are a team of 14 split between Bristol, UK, Texas and California composed of L&D experts and Games Developers
60%
Of Payroll is
Engineering
>90
eNPS
<30 days
Average ramp time
(as we use our own
product!)
12. Projections
We will grow to $xxM in revenue with strong margins by years 5/6
0
20
40
60
80
100
Yr1 Yr2 Yr3 Yr4 Yr5 Yr6
Millions
(USD)
Revenue - cash Gross Margin Overhead Profit before Tax
13. Opportunity
We’re Raising $10M Series A To Accelerate Growth
25%
12%
56%
7%
Sales & Marketing Cx Product Dev Other
Use of funds will focus on maximising cross-sell and upsell opportunities through product development, new products and new expertise
1. XX
2. XX
3. XX
15. I, the “Recipient”, hereby understand and agree that:
1. All information of any kind and nature provided in this presentation is considered confidential.
2. All such information shall not be disclosed in any way to any person, whether directly or indirectly
connected, or otherwise unrelated to the conduct of the prospective project and this presentation.
3. All the information in this presentation is the sole property of Virtihealth LTD. Prior written consent
from Virtihealth LTD must be obtained before reasonable disclosure is performed.
4. All copies of this presentation shall be returned to VirtiHealth LTD upon its immediate request of
such return or abrupt withdrawal by the same.
5. Materials including diagrams, text and research is copyright of Virtihealth ltd
6. Virti is a trademark of Virtihealth LTD and Virti Inc in the United Kingdom and United States.
Confidentiality